Evidence map›Paper›PMID 35084604›Full record

ArticleClinical rheumatology2022

Correction to: Effect of JAK inhibitors on high- and low-density lipoprotein in patients with rheumatoid arthritis: a systematic review and network meta-analysis.

Na Li, Zhong-Ping Gou, Shuang-Qing Du, Xiao-Hong Zhu, Hui Lin, Xiu-Fang Liang, Yong-Sheng Wang, Ping Feng

Abstract readPublished Erratum
PubMed Publisher
In one paragraph

Article in Clinical rheumatology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Na LiNational Medical Products Administration Key Laboratory for Clinical Research and Evaluation of Innovative Drugs, Institute of Clinical Trial Center, West China Hospital, Sichuan University, Chengdu, 610041, Sichuan, China.
Zhong-Ping GouNational Medical Products Administration Key Laboratory for Clinical Research and Evaluation of Innovative Drugs, Institute of Clinical Trial Center, West China Hospital, Sichuan University, Chengdu, 610041, Sichuan, China.
Shuang-Qing DuNational Medical Products Administration Key Laboratory for Clinical Research and Evaluation of Innovative Drugs, Institute of Clinical Trial Center, West China Hospital, Sichuan University, Chengdu, 610041, Sichuan, China.
Xiao-Hong ZhuNational Medical Products Administration Key Laboratory for Clinical Research and Evaluation of Innovative Drugs, Institute of Clinical Trial Center, West China Hospital, Sichuan University, Chengdu, 610041, Sichuan, China.
Hui LinDepartment of Rheumatology, West China Hospital, Sichuan University, Chengdu, 610041, Sichuan, China.
Xiu-Fang LiangNational Medical Products Administration Key Laboratory for Clinical Research and Evaluation of Innovative Drugs, Institute of Clinical Trial Center, West China Hospital, Sichuan University, Chengdu, 610041, Sichuan, China.
Yong-Sheng WangNational Medical Products Administration Key Laboratory for Clinical Research and Evaluation of Innovative Drugs, Institute of Clinical Trial Center, West China Hospital, Sichuan University, Chengdu, 610041, Sichuan, China.
Ping FengNational Medical Products Administration Key Laboratory for Clinical Research and Evaluation of Innovative Drugs, Institute of Clinical Trial Center, West China Hospital, Sichuan University, Chengdu, 610041, Sichuan, China. fengping@wchscu.cn.ORCID https://orcid.org/0000-0001-5488-0814

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID35084604

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.